Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Guaiazulene Sulfonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.40 |
| ▸ | P2RY4 known ✓ | P51582 | 5/20 | 0.38 |
| ▸ | P2RY2 known ✓ | P41231 | 4/20 | 0.38 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.36 |
| ▸ | P2RY1 known ✓ | P47900 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.40 |
| ▸ | MET | P08581 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guaiazulene Sulfonic Acid SCHEMBL29611830 | 1.00 | LMNA (0.44) | LMNATDP1TRPA1PTGS1CACNA1C | |
| Guaiazulene Sulfonic Acid SCHEMBL28273542 | 0.98 | LMNA (0.43) | LMNATDP1TRPA1PTGS1CACNA1C | |
| Guaiazulene Sulfonic Acid SCHEMBL2734180 | 0.83 | LMNA (0.46) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| Guaiazulene Sulfonic Acid SCHEMBL31632205 | 0.83 | LMNA (0.46) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| Guaiazulene Sulfonic Acid SCHEMBL9065336 | 0.81 | LMNA (0.44) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL10909584 | 0.81 | LMNA (0.47) | LMNATDP1PTGS1METALDH1A1 | |
| SCHEMBL10803721 | 0.80 | LMNA (0.43) | LMNATDP1P2RY4P2RY2MET | |
| SCHEMBL15878620 | 0.80 | ACHE (0.49) | LMNATDP1TRPA1PTGS1CACNA1C | |
| SCHEMBL15878449 | 0.79 | LMNA (0.42) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL10805589 | 0.77 | ALDH1A1 (0.42) | LMNATDP1P2RY4P2RY2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117534592-A | Method for synthesizing 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate | 许荧 | 2024-02-09 | — | — | CN | claimed |
| CN-117074572-A | Method for detecting related substances of 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate and related preparations thereof | 成都阿奇生物医药科技有限公司 | 2023-11-17 | — | — | CN | claimed |
| EP-4269542-A1 | A LUBRICANT USING VEGETABLE OIL AND HAVING A SELF-GENERATING FRICTION FILM | National Cheng Kung University (TW) | 2023-11-01 | — | — | EP | claimed |
| US-20230340352-A1 | LUBRICANT USING VEGETABLE OIL AND HAVING A SELF-GENERATING FRICTION FILM | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2023-10-26 | — | — | US | claimed |
| CN-114642685-A | Antibacterial and anti-inflammatory female intimate probiotic composition and preparation thereof | 王飞 | 2022-06-21 | — | — | CN | claimed |
| CN-114452379-A | Probiotic composition containing active lactic acid and preparation method thereof | 西安正浩生物制药有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-112438997-A | Effervescent tablet for self-made nasal spray | 北京瑞尚天启科技有限公司 | 2021-03-05 | — | — | CN | claimed |
| CN-112089680-A | Effervescent tablet for self-made mouthwash | 王飞 | 2020-12-18 | — | — | CN | claimed |
| CN-111973636-A | Anorectal gel and preparation method thereof | 王飞 | 2020-11-24 | — | — | CN | claimed |
| CN-111631991-A | Private nursing lotion | 王飞 | 2020-09-08 | — | — | CN | claimed |
| CN-111632073-A | Antibacterial and anti-inflammatory female privates probiotic composition and preparation thereof | 王飞 | 2020-09-08 | — | — | CN | claimed |
| CN-105561288-B | A kind of bioadhesive hydrogel and film containing alanyl glutamine | 重庆市人民医院 | 2019-05-07 | — | — | CN | claimed |
| CN-105561289-B | It is a kind of for treating the pharmaceutical preparation of canker sore | 重庆市人民医院 | 2019-05-07 | — | — | CN | claimed |
| CN-105561289-A | Pharmaceutic preparation for treating oral ulcer | CHONGQING PEOPLE'S HOSPITAL | 2016-05-11 | — | — | CN | claimed |
| CN-105561288-A | Alanyl-glutamine-containing bioadhesive hydrogel and membrane | CHONGQING PEOPLE'S HOSPITAL | 2016-05-11 | — | — | CN | claimed |
| CN-103405747-B | Preparation, product and application of alanyl glutamine biological adhesive preparation | THIRD PEOPLE S HOSPITAL OF CHONGQING | 2015-06-17 | — | — | CN | claimed |
| CN-102267929-B | Preparation of novel N-amino acid substituted azulene sulfamide medicine and anti-gastric ulcer actions thereof | Sichuan guokang pharmaceutical co ltd | 2014-02-19 | — | — | CN | claimed |
| CN-103405747-A | Preparation, product and application of alanyl glutamine biological adhesive preparation | THIRD PEOPLE S HOSPITAL OF CHONGQING | 2013-11-27 | — | — | CN | claimed |
| CN-102267929-A | Preparation of novel N-amino acid substituted azulene sulfamide medicine and anti-gastric ulcer actions thereof | — | 2011-12-07 | — | — | CN | claimed |
| JP-63048211-A | — | — | None | — | — | JP | disclosed |
| JP-61293912-A | — | — | None | — | — | JP | disclosed |
| JP-61151118-A | — | — | None | — | — | JP | disclosed |
| JP-2115121-A | — | — | None | — | — | JP | disclosed |
| JP-58083667-A | — | — | None | — | — | JP | disclosed |
| JP-63051341-A | — | — | None | — | — | JP | disclosed |
| JP-63297322-A | — | — | None | — | — | JP | disclosed |
| JP-1121216-A | — | — | None | — | — | JP | disclosed |
| JP-8081351-A | — | — | None | — | — | JP | disclosed |
| JP-56030927-A | — | — | None | — | — | JP | disclosed |
| JP-58013513-A | — | — | None | — | — | JP | disclosed |
| JP-63139118-A | — | — | None | — | — | JP | disclosed |
| JP-60188316-A | — | — | None | — | — | JP | disclosed |
| JP-5043423-A | — | — | None | — | — | JP | disclosed |
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | CLEARSIDE BIOMEDICAL, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | BEAUTY BIOLABS LLC (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4731305-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2026-04-29 | — | — | EP | disclosed |
| EP-4665372-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2025-12-24 | — | — | EP | disclosed |
| US-12485088-B2 | Rapidly-orodispersible tablets having an interior cavity | Aprecia Pharmaceuticals LLC (US) | 2025-12-02 | — | — | US | disclosed |
| US-20250345206-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| US-12350261-B2 | Methods and devices for the treatment of ocular diseases in human subjects | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-07-08 | — | — | US | disclosed |
| US-20250186253-A1 | DEVICES AND METHODS FOR ADJUSTING THE INSERTION DEPTH OF A NEEDLE FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-06-12 | — | — | US | disclosed |
| EP-4566672-A2 | METHODS FOR THE TREATMENT OF OCULAR DISEASE IN HUMAN SUBJECTS | Clearside Biomedical Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| US-12324856-B2 | Oral drug dosage form comprising drug in the form of nanoparticles | Triastek, Inc. (CN) | 2025-06-10 | — | — | US | disclosed |
| EP-3554435-B1 | SYSTEMS FOR DELIVERING DRUGS TO RETINAL TISSUE | CLEARSIDE BIOMEDICAL INC (US) | 2025-06-04 | — | — | EP | disclosed |
| US-20250152413-A1 | SYSTEMS, DEVICES, AND METHODS FOR NEEDLE-LESS OCULAR INJECTIONS | CLEARSIDE BIOMEDICAL INC (US) | 2025-05-15 | — | — | US | disclosed |
| WO-2025087269-A1 | NEW SHORT-CHAIN PEPTIDES AND DERIVATIVES THEREOF | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2025-05-01 | — | — | WO | disclosed |
| EP-4512394-A2 | DOSAGE FORMS AND USE THEREOF | Triastek, Inc. (CN) | 2025-02-26 | — | — | EP | disclosed |
| EP-3721872-B1 | METHODS FOR THE TREATMENT OF OCULAR DISEASE IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL INC (US) | 2025-01-22 | — | — | EP | disclosed |
| US-12201558-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| WO-2024260465-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2024-12-26 | — | — | WO | disclosed |
| US-20240408023-A1 | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES | Triastek, Inc. (CN) | 2024-12-12 | — | — | US | disclosed |
| EP-4171518-B1 | RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITY | Aprecia Pharmaceuticals LLC (US) | 2024-12-11 | — | — | EP | disclosed |
| US-12127975-B2 | Devices and methods for adjusting the insertion depth of a needle for medicament delivery | CLEARSIDE BIOMEDICAL, INC. (US) | 2024-10-29 | — | — | US | disclosed |
| CN-118845572-A | Anti-sensitization type cleaning toothpaste and preparation method thereof | 深圳市康杰尔生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-20240342094-A1 | COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS | Triastek, Inc. (CN) | 2024-10-17 | — | — | US | disclosed |
| EP-3302442-B1 | DOSAGE FORMS AND USE THEREOF | TRIASTEK INC (CN) | 2024-10-16 | — | — | EP | disclosed |
| EP-3496680-B1 | DEVICE FOR ADJUSTING THE INSERTION DEPTH OF A NEEDLE FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL INC (US) | 2024-10-02 | — | — | EP | disclosed |
| US-12102721-B2 | Dosage forms of controlled release at specific gastrointestinal sites | Triastek, Inc. (CN) | 2024-10-01 | — | — | US | disclosed |
| WO-2024169972-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2024-08-22 | — | — | WO | disclosed |
| US-12042562-B2 | 3D printing methods for compartmented pharmaceutical dosage forms | Triastek, Inc. (CN) | 2024-07-23 | — | — | US | disclosed |
| US-12005070-B2 | Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder | TOYO SUGAR REFINING CO., LTD. (JP) | 2024-06-11 | — | — | US | disclosed |
| EP-4378444-A2 | APPARATUS AND METHODS FOR OCULAR INJECTION | Clearside Biomedical, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| US-20240165247-A1 | NEW PEPTIDE CONJUGATES | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2024-05-23 | — | — | US | disclosed |
| US-20240165089-A1 | METHOD FOR TREATING MYOPIA WITH VINPOCETINE | Eye Hospital, Wenzhou Medical University (CN) | 2024-05-23 | — | — | US | disclosed |
| EP-4364736-A1 | METHOD FOR TREATING MYOPIA WITH VINPOCETINE | The Eye Hospital of Wenzhou Medical University (CN) | 2024-05-08 | — | — | EP | disclosed |
| CN-114957081-B | Azulene compounds, intermediates, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2024-04-05 | — | — | CN | disclosed |
| CN-117534592-A | Method for synthesizing 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate | 许荧 | 2024-02-09 | — | — | CN | disclosed |
| CN-117534592-A | Method for synthesizing 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate | 许荧 | 2024-02-09 | — | — | CN | disclosed |
| CN-117534592-A | Method for synthesizing 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate | 许荧 | 2024-02-09 | — | — | CN | disclosed |
| CN-117462429-A | Preparation method of oral cavity grade component sterilization wet tissue for infants | 扬州倍加洁日化有限公司 | 2024-01-30 | — | — | CN | disclosed |
| EP-3417896-B1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL INC (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-4308167-A1 | NEW PEPTIDE CONJUGATES | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2024-01-24 | — | — | EP | disclosed |
| WO-2024015652-A1 | SYSTEMS, DEVICES, AND METHODS FOR NEEDLE-LESS OCULAR INJECTIONS | CLEARSIDE BIOMEDICAL, INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| US-20240009106-A1 | KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS | BEAUTY BIOLABS LLC | 2024-01-11 | — | — | US | disclosed |
| CN-117126032-A | Azulene compound, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2023-11-28 | — | — | CN | disclosed |
| CN-117074572-A | Method for detecting related substances of 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate and related preparations thereof | 成都阿奇生物医药科技有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-117074572-A | Method for detecting related substances of 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate and related preparations thereof | 成都阿奇生物医药科技有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-117074572-A | Method for detecting related substances of 1, 4-dimethyl-7-isopropyl azulene-3-sodium sulfonate and related preparations thereof | 成都阿奇生物医药科技有限公司 | 2023-11-17 | — | — | CN | disclosed |
| US-20230363941-A1 | APPARATUS AND METHODS OF RETINAL INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| EP-4269542-A1 | A LUBRICANT USING VEGETABLE OIL AND HAVING A SELF-GENERATING FRICTION FILM | National Cheng Kung University (TW) | 2023-11-01 | — | — | EP | disclosed |
| US-20230340352-A1 | LUBRICANT USING VEGETABLE OIL AND HAVING A SELF-GENERATING FRICTION FILM | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2023-10-26 | — | — | US | disclosed |
| US-20230331792-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2023-10-19 | — | — | US | disclosed |
| EP-3413851-B1 | PACKAGING | CLEARSIDE BIOMEDICAL INC (US) | 2023-09-27 | — | — | EP | disclosed |
| US-11752085-B2 | Keratin-based hair straightening formulations, methods and systems | BEAUTY BIOLABS LLC (US) | 2023-09-12 | — | — | US | disclosed |
| US-20230270665-A1 | RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITY | Aprecia Pharmaceuticals LLC | 2023-08-31 | — | — | US | disclosed |
| EP-4225235-A1 | APPARATUS AND METHODS OF RETINAL INJECTION | Clearside Biomedical, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| US-20230157869-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| EP-4171518-A1 | RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITY | Aprecia Pharmaceuticals LLC (US) | 2023-05-03 | — | — | EP | disclosed |
| US-20230113836-A1 | NEW CONJUGATES OF PEPTIDES AND POLYSACCHARIDE | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2023-04-13 | — | — | US | disclosed |
| US-20230083551-A1 | Formulations for the Suprachoroidal Space of an Eye and Methods | EMORY UNIVERSITY | 2023-03-16 | — | — | US | disclosed |
| US-11596545-B2 | Systems and methods for ocular drug delivery | CLEARSIDE BIOMEDICAL, INC. (US) | 2023-03-07 | — | — | US | disclosed |
| US-11559428-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC. (US) | 2023-01-24 | — | — | US | disclosed |
| US-20230017654-A1 | ANTI-INFLAMMATORY LIQUID COMPOSITION FOR COVERING ORAL MUCOSA AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF STOMATITIS USING SAME | HANIC WHITE LABO CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| EP-2887982-B1 | APPARATUS FOR DRUG DELIVERY USING MICRONEEDLES | CLEARSIDE BIOMEDICAL INC (US) | 2022-11-23 | — | — | EP | disclosed |
| US-11504431-B2 | Formulations for the suprachoroidal space of an eye and methods | EMORY UNIVERSITY (US) | 2022-11-22 | — | — | US | disclosed |
| EP-4079281-A1 | ANTI-INFLAMMATORY LIQUID COMPOSITION FOR COVERING ORAL MUCOSA, AND MEDICINAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF STOMATITIS USING SAME | Hanic White Labo Co., Ltd. (JP) | 2022-10-26 | — | — | EP | disclosed |
| EP-4069275-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2022-10-12 | — | — | EP | disclosed |
| EP-4069713-A1 | NEW CONJUGATES OF PEPTIDES AND POLYSACCHARIDE | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2022-10-12 | — | — | EP | disclosed |
| WO-2022194238-A1 | NEW PEPTIDE CONJUGATES | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2022-09-22 | — | — | WO | disclosed |
| WO-2022193185-A1 | NEW CONJUGATES | JIANGYIN USUN PHARMACEUTICAL CO., LTD. (CN) | 2022-09-22 | — | — | WO | disclosed |
| US-20220280341-A1 | APPARATUS AND METHODS FOR DRUG DELIVERY USING MICRONEEDLES | CLEARSIDE ROYALTY LLC | 2022-09-08 | — | — | US | disclosed |
| US-20220280386-A1 | METHODS AND APPARATUS FOR EXTRACTING FLUID FROM CONTAINER | CLEARSIDE BIOMEDICAL, INC. | 2022-09-08 | — | — | US | disclosed |
| US-11433022-B2 | Rapidly-orodispersible tablets having an in interior cavity | Aprecia Pharmaceuticals LLC (US) | 2022-09-06 | — | — | US | disclosed |
| CN-114957081-A | Azulene compounds, intermediates thereof, preparation methods and uses thereof | 中国科学院上海有机化学研究所 | 2022-08-30 | — | — | CN | disclosed |
| CN-114642685-A | Antibacterial and anti-inflammatory female intimate probiotic composition and preparation thereof | 王飞 | 2022-06-21 | — | — | CN | disclosed |
| CN-114452379-A | Probiotic composition containing active lactic acid and preparation method thereof | 西安正浩生物制药有限公司 | 2022-05-10 | — | — | CN | disclosed |
| WO-2022076938-A1 | APPARATUS AND METHODS OF RETINAL INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2022-04-14 | — | — | WO | disclosed |
| EP-3981392-A1 | CONTROLLED RELEASE DOSAGE FORM | Triastek, Inc. (CN) | 2022-04-13 | — | — | EP | disclosed |
| EP-2694834-B2 | KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS | BAUM MARC MICHAEL (US) | 2022-04-06 | — | — | EP | disclosed |
| US-11278499-B2 | Oral drug dosage form comprising various release profiles | Triastek, Inc. (CN) | 2022-03-22 | — | — | US | disclosed |
| US-20220054409-A1 | RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITY | Aprecia Pharmaceuticals LLC | 2022-02-24 | — | — | US | disclosed |
| WO-2021263132-A1 | RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITY | Aprecia Pharmaceuticals LLC (US) | 2021-12-30 | — | — | WO | disclosed |
| CN-113582884-A | Preparation method of sodium azulene sulfonate monohydrate with high stability | 成都大学 | 2021-11-02 | — | — | CN | disclosed |
| US-20210220173-A1 | DEVICES AND METHODS FOR ADJUSTING THE INSERTION DEPTH OF A NEEDLE FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2021-07-22 | — | — | US | disclosed |
| US-20210205226-A1 | ORAL DRUG DOSAGE FORM COMPRISING DRUG IN THE FORM OF NANOPARTICLES | Triastek, Inc. (CN) | 2021-07-08 | — | — | US | disclosed |
| EP-2991706-B1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL INC (US) | 2021-06-23 | — | — | EP | disclosed |
| WO-2021110064-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | JIANGYIN USUN BIOCHEMICAL TECHNOLOGY CO., LTD. (CN) | 2021-06-10 | — | — | WO | disclosed |
| WO-2021110063-A1 | NEW CONJUGATES OF PEPTIDES AND POLYSACCHARIDE | JIANGYIN USUN BIOCHEMICAL TECHNOLOGY CO., LTD. (CN) | 2021-06-10 | — | — | WO | disclosed |
| US-20210128479-A1 | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES | Triastek, Inc. (CN) | 2021-05-06 | — | — | US | disclosed |
| CN-111362844-B | Synthetic method of azulene sulfonamide | 西南民族大学 | 2021-04-27 | — | — | CN | disclosed |
| US-10973767-B2 | Oral drug dosage form comprising drug in the form of nanoparticles | Triastek, Inc. (CN) | 2021-04-13 | — | — | US | disclosed |
| US-10973681-B2 | Devices and methods for adjusting the insertion depth of a needle for medicament delivery | CLEARSIDE BIOMEDICAL, INC. (US) | 2021-04-13 | — | — | US | disclosed |
| CN-112438997-A | Effervescent tablet for self-made nasal spray | 北京瑞尚天启科技有限公司 | 2021-03-05 | — | — | CN | disclosed |
| CN-112089680-A | Effervescent tablet for self-made mouthwash | 王飞 | 2020-12-18 | — | — | CN | disclosed |
| US-20200383965-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. | 2020-12-10 | — | — | US | disclosed |
| CN-111973636-A | Anorectal gel and preparation method thereof | 王飞 | 2020-11-24 | — | — | CN | disclosed |
| EP-3721872-A1 | METHODS FOR THE TREATMENT OF OCULAR DISEASE IN HUMAN SUBJECTS | Clearside Biomedical Inc. (US) | 2020-10-14 | — | — | EP | disclosed |
| US-20200315971-A1 | 3D PRINTING METHODS FOR COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS | Triastek, Inc. (CN) | 2020-10-08 | — | — | US | disclosed |
| CN-111631991-A | Private nursing lotion | 王飞 | 2020-09-08 | — | — | CN | disclosed |
| CN-111632073-A | Antibacterial and anti-inflammatory female privates probiotic composition and preparation thereof | 王飞 | 2020-09-08 | — | — | CN | disclosed |
| US-10722396-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL., INC. (US) | 2020-07-28 | — | — | US | disclosed |
| CN-111362844-A | Synthetic method of azulene sulfonamide | 西南民族大学 | 2020-07-03 | — | — | CN | disclosed |
| WO-2020133091-A1 | PYRIDYLOXY CARBOXYLATE DERIVATIVE, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | 青岛清原化合物有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020133092-A1 | PYRIDYLOXY-CARBOXYLATE DERIVATIVE AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND USE | 青岛清原化合物有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020133403-A1 | SUBSTITUTED PYRIMIDINE ARYL ESTER DERIVATIVE, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND APPLICATION THEREOF | 青岛清原化合物有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020133090-A1 | PYRIDYLOXY THIOESTER DERIVATIVE AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND APPLICATION | 青岛清原化合物有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020135235-A1 | R-TYPE PYRIDYLOXYCARBOXYLIC ACID, SALT AND ESTER DERIVATIVE THEREOF, AND PREPARATION METHOD THEREFOR, AND HERBICIDAL COMPOSITION AND APPLICATION THEREOF | 青岛清原化合物有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020135236-A1 | PYRIDYL OXYCARBOXYLIC ACID OXIME DERIVATIVE AND PREPARATION METHOD THEREFOR, WEEDING COMPOSITION AND APPLICATION THEREOF | 青岛清原化合物有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020118754-A1 | TERNARY WEEDING COMPOSITION CONTAINING PYROXASULFONE AND USE THEREOF | 青岛清原化合物有限公司 | 2020-06-18 | — | — | WO | disclosed |
| CN-108464963-B | Composition for oral cavity and application and preparation method thereof | 弘美制药（中国）有限公司 | 2020-06-16 | — | — | CN | disclosed |
| CN-108175730-B | Composition for oral cavity and application and preparation method thereof | 弘美制药（中国）有限公司 | 2020-06-16 | — | — | CN | disclosed |
| US-20200179473-A1 | ANTI-PATHOGENIC COMPOSITIONS | ANJON BIOLOGICS INC (US) | 2020-06-11 | — | — | US | disclosed |
| EP-2916827-B1 | METHODS FOR THE TREATMENT OF OCULAR DISEASE IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL INC (US) | 2020-06-10 | — | — | EP | disclosed |
| CN-111067858-A | Skin care powder | 王飞 | 2020-04-28 | — | — | CN | disclosed |
| CN-110876742-A | Pharmaceutical composition for repairing skin injury and application thereof | 广州家安化妆品有限公司 | 2020-03-13 | — | — | CN | disclosed |
| US-10555833-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC. (US) | 2020-02-11 | — | — | US | disclosed |
| US-20200030143-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2020-01-30 | — | — | US | disclosed |
| EP-3003454-B1 | APPARATUS FOR DRUG DELIVERY USING MULTIPLE RESERVOIRS | CLEARSIDE BIOMEDICAL INC (US) | 2020-01-08 | — | — | EP | disclosed |
| US-10517756-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC (US) | 2019-12-31 | — | — | US | disclosed |
| US-20190350755-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2019-11-21 | — | — | US | disclosed |
| US-20190321299-A1 | ORAL DRUG DOSAGE FORM COMPRISING VARIOUS RELEASE PROFILES | Triastek, Inc. (CN) | 2019-10-24 | — | — | US | disclosed |
| EP-3554435-A1 | SYSTEMS AND METHODS FOR DELIVERING DRUGS TO RETINAL TISSUE | Clearside Biomedical, Inc. (US) | 2019-10-23 | — | — | EP | disclosed |
| US-20190307606-A1 | SYSTEMS AND METHODS FOR OCULAR DRUG DELIVERY | CLEARSIDE BIOMEDICAL, INC. | 2019-10-10 | — | — | US | disclosed |
| CN-110302004-A | Device and method for ocular injection | 科尼尔赛德生物医学公司 | 2019-10-08 | — | — | CN | disclosed |
| CN-110290781-A | The dosage form of stomach and intestine privileged site control release | 南京三迭纪医药科技有限公司 | 2019-09-27 | — | — | CN | disclosed |
| US-20190290485-A1 | SYSTEMS AND METHODS FOR DELIVERING DRUGS TO RETINAL TISSUE | CLEARSIDE BIOMEDICAL, INC. (US) | 2019-09-26 | — | — | US | disclosed |
| EP-2783689-B1 | KERATOCONJUNCTIVAL PROTECTING AGENT, OR KERATOCONJUNCTIVAL DISORDER INHIBITING AGENT | TOYO SUGAR REFINING CO LTD (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-10390901-B2 | Ocular injection kit, packaging, and methods of use | CLEARSIDE BIOMEDICAL, INC. (US) | 2019-08-27 | — | — | US | disclosed |
| CN-110177527-A | Device and method for adjusting insertion depth of needle for medicament delivery | 科尼尔赛德生物医学公司 | 2019-08-27 | — | — | CN | disclosed |
| US-20190240208-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. | 2019-08-08 | — | — | US | disclosed |
| US-20190240336-A1 | Formulations for the Suprachoroidal Space of an Eye and Methods | EMORY UNIVERSITY (US) | 2019-08-08 | — | — | US | disclosed |
| US-20190231592-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2019-08-01 | — | — | US | disclosed |
| US-10363220-B2 | Compartmented pharmaceutical dosage forms | Triastek, Inc. (CN) | 2019-07-30 | — | — | US | disclosed |
| US-20190192440-A1 | ORAL DRUG DOSAGE FORM COMPRISING DRUG IN THE FORM OF NANOPARTICLES | Triastek, Inc. (CN) | 2019-06-27 | — | — | US | disclosed |
| CN-106748912-B | A kind of synthesis technology of sodium azulenesulfonate monohydrate | 南京济群医药科技股份有限公司 | 2019-06-21 | — | — | CN | disclosed |
| EP-3496680-A1 | DEVICES AND METHODS FOR ADJUSTING THE INSERTION DEPTH OF A NEEDLE FOR MEDICAMENT DELIVERY | Clearside Biomedical, Inc. (US) | 2019-06-19 | — | — | EP | disclosed |
| CN-105246529-B | apparatus and method for ocular injection | 科尼尔赛德生物医学公司 | 2019-06-14 | — | — | CN | disclosed |
| EP-3487586-A1 | FORMULATIONS FOR THE SUPRACHOROIDAL SPACE OF AN EYE AND METHODS | Emory University (US) | 2019-05-29 | — | — | EP | disclosed |
| CN-105561288-B | A kind of bioadhesive hydrogel and film containing alanyl glutamine | 重庆市人民医院 | 2019-05-07 | — | — | CN | disclosed |
| CN-105561289-B | It is a kind of for treating the pharmaceutical preparation of canker sore | 重庆市人民医院 | 2019-05-07 | — | — | CN | disclosed |
| US-10258575-B2 | Oral drug dosage forms having desired drug release profiles and uses thereof | Triastek, Inc. (CN) | 2019-04-16 | — | — | US | disclosed |
| CN-109549920-A | Aqueous formulation | 钻石制药株式会社 | 2019-04-02 | — | — | CN | disclosed |
| CN-109549920-A | Aqueous formulation | 钻石制药株式会社 | 2019-04-02 | — | — | CN | disclosed |
| EP-3452003-A1 | CONTROLLED RELEASE DOSAGE FORM | Triastek, Inc. (CN) | 2019-03-13 | — | — | EP | disclosed |
| EP-3452165-A1 | SYSTEMS AND METHODS FOR OCULAR DRUG DELIVERY | Clearside Biomedical, Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| CN-109431965-A | Pharmaceutical formulation and its use | 南京三迭纪医药科技有限公司 | 2019-03-08 | — | — | CN | disclosed |
| CN-109432039-A | Pharmaceutical formulation and its use | 南京三迭纪医药科技有限公司 | 2019-03-08 | — | — | CN | disclosed |
| CN-109431854-A | A kind of bFGF acne hole maintenance freeze-dried powder preparation and preparation method thereof | 广州丽彦妆生物科技有限公司 | 2019-03-08 | — | — | CN | disclosed |
| US-10188550-B2 | Apparatus and methods for drug delivery using multiple reservoirs | CLEARSIDE BIOMEDICAL, INC. (US) | 2019-01-29 | — | — | US | disclosed |
| WO-2018137686-A9 | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES | Triastek, Inc. (CN) | 2018-12-27 | — | — | WO | disclosed |
| EP-3417896-A2 | APPARATUS AND METHODS FOR OCULAR INJECTION | Clearside Biomedical, Inc. (US) | 2018-12-26 | — | — | EP | disclosed |
| EP-3413851-A1 | OCULAR INJECTION KIT, PACKAGING, AND METHODS OF USE | Clearside Biomedical, Inc. (US) | 2018-12-19 | — | — | EP | disclosed |
| US-10143626-B2 | Controlled release dosage form | Triastek, Inc. (CN) | 2018-12-04 | — | — | US | disclosed |
| US-20180333297-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2018-11-22 | — | — | US | disclosed |
| US-20180325884-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. | 2018-11-15 | — | — | US | disclosed |
| EP-3400014-A1 | METHODS AND DEVICES FOR TREATING POSTERIOR OCULAR DISORDERSWITH AFLIBERCEPT AND OTHER BIOLOGICS | Clearside Biomedical, Inc. (US) | 2018-11-14 | — | — | EP | disclosed |
| CN-108778330-A | With the method and apparatus of ophthalmic disorders after VEGF Trap and other biological products therapies | 科尼尔赛德生物医学公司 | 2018-11-09 | — | — | CN | disclosed |
| US-20180311167-A1 | DOSAGE FORMS AND USE THEREOF | Triastek, Inc. (CN) | 2018-11-01 | — | — | US | disclosed |
| CN-106680413-B | A kind of RT-HPLC detection method of the sodium azulenesulfonate in relation to substance | 南京济群医药科技股份有限公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108498357-A | A kind of human-like collagen facial mask liquid and preparation method thereof | 广州丽彦妆生物科技有限公司 | 2018-09-07 | — | — | CN | disclosed |
| CN-108478453-A | Hyaluronic acid face mask liquid and preparation method thereof | 广州丽彦妆生物科技有限公司 | 2018-09-04 | — | — | CN | disclosed |
| WO-2018137686-A1 | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES | Triastek, Inc. (CN) | 2018-08-02 | — | — | WO | disclosed |
| CN-108309840-A | A kind of profession repair membrane facial mask liquid and preparation method thereof | 广州丽彦妆生物科技有限公司 | 2018-07-24 | — | — | CN | disclosed |
| WO-2018111862-A1 | SYSTEMS AND METHODS FOR DELIVERING DRUGS TO RETINAL TISSUE | CLEARSIDE BIOMEDICAL, INC. (US) | 2018-06-21 | — | — | WO | disclosed |
| US-20180161438-A1 | Aqueous Ophthalmic Composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2018-06-14 | — | — | US | disclosed |
| US-20180116911-A1 | CONTROLLED RELEASE DOSAGE FORM | Triastek, Inc. (CN) | 2018-05-03 | — | — | US | disclosed |
| US-9956114-B2 | Variable diameter cannula and methods for controlling insertion depth for medicament delivery | CLEARSIDE BIOMEDICAL, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| CN-107951733-A | The preparation and its application of Azulene sodium sulfonate and Cetylpyridinium Chloride compound mouthwash | 江苏大学 | 2018-04-24 | — | — | CN | disclosed |
| EP-3302442-A1 | DOSAGE FORMS AND USE THEREOF | Triastek, Inc. (CN) | 2018-04-11 | — | — | EP | disclosed |
| US-9937075-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC. (US) | 2018-04-10 | — | — | US | disclosed |
| US-20180092897-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. | 2018-04-05 | — | — | US | disclosed |
| US-9931330-B2 | Methods and devices for the treatment of ocular diseases in human subjects | CLEARSIDE BIOMEDICAL, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| CN-107847426-A | Antiviral composition | 安乔生物制品股份有限公司 | 2018-03-27 | — | — | CN | disclosed |
| US-20180064775-A1 | ANTI-PATHOGENIC COMPOSITIONS | ANJON BIOLOGICS, INC. | 2018-03-08 | — | — | US | disclosed |
| US-20180042767-A1 | DEVICES AND METHODS FOR ADJUSTING THE INSERTION DEPTH OF A NEEDLE FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2018-02-15 | — | — | US | disclosed |
| US-20180042765-A1 | METHODS AND DEVICES FOR TREATING POSTERIOR OCULAR DISORDERS | CLEARSIDE BIOMEDICAL, INC. | 2018-02-15 | — | — | US | disclosed |
| WO-2018031913-A1 | DEVICES AND METHODS FOR ADJUSTING THE INSERTION DEPTH OF A NEEDLE FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2018-02-15 | — | — | WO | disclosed |
| US-20180028516-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. | 2018-02-01 | — | — | US | disclosed |
| US-20180028358-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2018-02-01 | — | — | US | disclosed |
| WO-2018017899-A1 | FORMULATIONS FOR THE SUPRACHOROIDAL SPACE OF AN EYE AND METHODS | EMORY UNIVERSITY (US) | 2018-01-25 | — | — | WO | disclosed |
| EP-3270888-A1 | ANTI-PATHOGENIC COMPOSITIONS | Anjon Biologics Inc. (US) | 2018-01-24 | — | — | EP | disclosed |
| US-20170333416-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE ROYALTY LLC | 2017-11-23 | — | — | US | disclosed |
| WO-2017193099-A1 | CONTROLLED RELEASE DOSAGE FORM | LI XIAOLING (US) | 2017-11-09 | — | — | WO | disclosed |
| WO-2017192565-A1 | SYSTEMS AND METHODS FOR OCULAR DRUG DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| US-20170273827-A1 | APPARATUS AND METHODS FOR DRUG DELIVERY USING MICRONEEDLES | CLEARSIDE BIOMEDICAL, INC. | 2017-09-28 | — | — | US | disclosed |
| US-9770361-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-09-26 | — | — | US | disclosed |
| CN-107072765-A | Method and apparatus for ocular disorders after treatment | 科尼尔赛德生物医学公司 | 2017-08-18 | — | — | CN | disclosed |
| WO-2017139375-A1 | OCULAR INJECTION KIT, PACKAGING, AND METHODS OF USE | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-08-17 | — | — | WO | disclosed |
| US-20170224534-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-08-10 | — | — | US | disclosed |
| US-20170224435-A1 | OCULAR INJECTION KIT, PACKAGING, AND METHODS OF USE | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-08-10 | — | — | US | disclosed |
| US-9724312-B2 | Agent for the prevention, improvement or treatment of retinal disease | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2017-08-08 | — | — | US | disclosed |
| WO-2017120601-A1 | METHODS AND DEVICES FOR TREATING POSTERIOR OCULAR DISORDERSWITH AFLIBERCEPT AND OTHER BIOLOGICS | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-07-13 | — | — | WO | disclosed |
| CN-106794321-A | Variable-diameter intubation and for controlling the method to the insertion depth of drug delivery | 科尼尔赛德生物医学公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106692099-A | Glutamine acid amide compound film-coated tablets and preparation method thereof | 南京济群医药科技股份有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-106680413-A | RT-HPLC detecting method of relevant matters of sodium gualenate | 南京济群医药科技股份有限公司 | 2017-05-17 | — | — | CN | disclosed |
| CN-106680413-A | RT-HPLC detecting method of relevant matters of sodium gualenate | 南京济群医药科技股份有限公司 | 2017-05-17 | — | — | CN | disclosed |
| CN-106680413-A | RT-HPLC detecting method of relevant matters of sodium gualenate | 南京济群医药科技股份有限公司 | 2017-05-17 | — | — | CN | disclosed |
| US-9636253-B1 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-05-02 | — | — | US | disclosed |
| US-9636332-B2 | Methods and devices for the treatment of ocular diseases in human subjects | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-05-02 | — | — | US | disclosed |
| US-20170112665-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-04-27 | — | — | US | disclosed |
| EP-3157598-A2 | VARIABLE DIAMETER CANNULA AND METHODS FOR CONTROLLING INSERTION DEPTH FOR MEDICAMENT DELIVERY | Clearside Biomedical, Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| EP-3157463-A1 | METHODS AND DEVICES FOR TREATING POSTERIOR OCULAR DISORDERS | Clearside Biomedical, Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| CN-106580941-A | Mouthwash powder containing sodium gualenate and preparation method thereof | 河北医科大学生物医学工程中心 | 2017-04-26 | — | — | CN | disclosed |
| CN-106580941-A | Mouthwash powder containing sodium gualenate and preparation method thereof | 河北医科大学生物医学工程中心 | 2017-04-26 | — | — | CN | disclosed |
| US-20170095369-A1 | VARIABLE DIAMETER CANNULA AND METHODS FOR CONTROLLING INSERTION DEPTH FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-04-06 | — | — | US | disclosed |
| US-9572800-B2 | Methods and devices for the treatment of ocular diseases in human subjects | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-02-21 | — | — | US | disclosed |
| US-9539139-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC. (US) | 2017-01-10 | — | — | US | disclosed |
| US-20160367584-A1 | PROTECTIVE AGENT FOR KERATOCONJUNCTIVA OR SUPPRESSIVE AGENT FOR KERATOCONJUNCTIVAL DISORDER | TOYO SUGAR REFINING CO., LTD. (JP) | 2016-12-22 | — | — | US | disclosed |
| CN-106236715-A | Pharmaceutical dosage forms and uses thereof | 南京三迭纪医药科技有限公司 | 2016-12-21 | — | — | CN | disclosed |
| WO-2016192680-A1 | DOSAGE FORMS AND USE THEREOF | Triastek, Inc. (CN) | 2016-12-08 | — | — | WO | disclosed |
| US-20160354315-A1 | DOSAGE FORMS AND USE THEREOF | Triastek, Inc. (CN) | 2016-12-08 | — | — | US | disclosed |
| US-20160310417-A1 | Formulations and Methods For Targeted Ocular Delivery of Therapeutic Agents | NATIONAL INSTITUTES OF HEALTH - DIRECTOR | 2016-10-27 | — | — | US | disclosed |
| EP-3082761-A2 | FORMULATIONS AND METHODS FOR TARGETED OCULAR DELIVERY OF THERAPEUTIC AGENTS | Emory University (US) | 2016-10-26 | — | — | EP | disclosed |
| WO-2016147142-A1 | ANTI-PATHOGENIC COMPOSITIONS | ANJON BIOLOGICS, INC. (US) | 2016-09-22 | — | — | WO | disclosed |
| US-20160213662-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. | 2016-07-28 | — | — | US | disclosed |
| US-20160206628-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. (US) | 2016-07-21 | — | — | US | disclosed |
| CN-105748385-A | Toothpaste for improving gingival blood circulation, and maintaining periodontal and oral mucosa health | 安徽万春日化有限公司 | 2016-07-13 | — | — | CN | disclosed |
| US-9376382-B2 | N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof | SICHUAN GUOKANG PHARMACEUTICAL CO., LTD. (CN) | 2016-06-28 | — | — | US | disclosed |
| US-20160136275-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2016-05-19 | — | — | US | disclosed |
| CN-105561289-A | Pharmaceutic preparation for treating oral ulcer | CHONGQING PEOPLE'S HOSPITAL | 2016-05-11 | — | — | CN | disclosed |
| CN-105561288-A | Alanyl-glutamine-containing bioadhesive hydrogel and membrane | CHONGQING PEOPLE'S HOSPITAL | 2016-05-11 | — | — | CN | disclosed |
| US-20160106584-A1 | APPARATUS AND METHODS FOR DRUG DELIVERY USING MULTIPLE RESERVOIRS | CLEARSIDE BIOMEDICAL, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| CN-105482365-A | Attapulgite based 3D printer bracket and preparation method thereof | ANHUI CHUNGU 3D PRINTING INTELLIGENT EQUIPMENT IND TECH RES INST CO LTD | 2016-04-13 | — | — | CN | disclosed |
| US-20160089345-A1 | KIT OF OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2016-03-31 | — | — | US | disclosed |
| CN-105246529-A | Apparatus and method for ocular injection | CLEARSIDE BIOMEDICAL INC | 2016-01-13 | — | — | CN | disclosed |
| WO-2015196085-A2 | VARIABLE DIAMETER CANNULA AND METHODS FOR CONTROLLING INSERTION DEPTH FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| WO-2015195842-A1 | METHODS AND DEVICES FOR TREATING POSTERIOR OCULAR DISORDERS | CLEARSIDE BIOMEDICAL, INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| US-9180047-B2 | Apparatus and methods for ocular injection | CLEARSIDE BIOMEDICAL, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| CN-104983844-A | Edible composition formula with mucous-membrane restoring function and preparation process of preparation thereof | TIANJIN JUXING KANGHUA MEDICAL TECHNOLOGY CO LTD | 2015-10-21 | — | — | CN | disclosed |
| US-20150258120-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. | 2015-09-17 | — | — | US | disclosed |
| EP-2916827-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | Clearside Biomedical Inc. (US) | 2015-09-16 | — | — | EP | disclosed |
| CN-104884049-A | Methods and devices for treating ocular diseases in human subjects | CLEARSIDE BIOMEDICAL INC | 2015-09-02 | — | — | CN | disclosed |
| US-20150209180-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | CLEARSIDE BIOMEDICAL, INC. (US) | 2015-07-30 | — | — | US | disclosed |
| EP-2887982-A1 | APPARATUS AND METHODS FOR DRUG DELIVERY USING MICRONEEDLES | Clearside Biomedical, Inc. (US) | 2015-07-01 | — | — | EP | disclosed |
| WO-2015095772-A2 | FORMULATIONS AND METHODS FOR TARGETED OCULAR DELIVERY OF THERAPEUTIC AGENTS | EMORY UNIVERSITY (US) | 2015-06-25 | — | — | WO | disclosed |
| CN-103405747-B | Preparation, product and application of alanyl glutamine biological adhesive preparation | THIRD PEOPLE S HOSPITAL OF CHONGQING | 2015-06-17 | — | — | CN | disclosed |
| CN-104688552-A | Antiallergic medicinal bath foam containing sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-06-10 | — | — | CN | disclosed |
| CN-104688552-A | Antiallergic medicinal bath foam containing sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-06-10 | — | — | CN | disclosed |
| CN-104688619-A | Sodium gualenate antiallergic facial cleanser | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-06-10 | — | — | CN | disclosed |
| CN-104666285-A | Anti-allergic disposable quick-drying hand cleaner of sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-06-03 | — | — | CN | disclosed |
| CN-104666285-A | Anti-allergic disposable quick-drying hand cleaner of sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-06-03 | — | — | CN | disclosed |
| CN-104644460-A | Medicinal toothpaste composition and preparation method and application thereof | BEIJING HWELLSO PHARMACEUTICAL CO LTD | 2015-05-27 | — | — | CN | disclosed |
| CN-104586638-A | Scalp care solution containing sodium gualenate and shampoo | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-05-06 | — | — | CN | disclosed |
| CN-104586699-A | Bodybuilding body film containing sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-05-06 | — | — | CN | disclosed |
| CN-104586699-A | Bodybuilding body film containing sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-05-06 | — | — | CN | disclosed |
| CN-104586638-A | Scalp care solution containing sodium gualenate and shampoo | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2015-05-06 | — | — | CN | disclosed |
| US-20150051581-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2015-02-19 | — | — | US | disclosed |
| US-20150038905-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2015-02-05 | — | — | US | disclosed |
| US-20150025154-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2015-01-22 | — | — | US | disclosed |
| US-20140350119-A1 | OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE | ROHTO PHARMA (JP) | 2014-11-27 | — | — | US | disclosed |
| US-20140315836-A1 | PROTECTIVE AGENT FOR KERATOCONJUNCTIVA OR SUPPRESSIVE AGENT FOR KERATOCONJUNCTIVAL DISORDER | TOYO SUGAR REFINING CO., LTD. (JP) | 2014-10-23 | — | — | US | disclosed |
| EP-2783689-A1 | KERATOCONJUNCTIVAL PROTECTING AGENT, OR KERATOCONJUNCTIVAL DISORDER INHIBITING AGENT | Toyo Sugar Refining Co., Ltd. (JP) | 2014-10-01 | — | — | EP | disclosed |
| US-20140243419-A1 | MUCOSALLY-APPLIED AGENT FOR PREVENTION, AMELIORATION OR TREATMENT OF RETINAL DISEASE | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
| US-20140206741-A1 | N-SUBSTITUTED ISOPROPYLDIMETHYL AZULENE SULFONAMIDE DERIVATIVES, AND PREPARATION METHOD AND USE THEREOF | SICHUAN GUOKANG PHARMACEUTICAL CO., LTD (CN) | 2014-07-24 | — | — | US | disclosed |
| WO-2014074823-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL, INC. (US) | 2014-05-15 | — | — | WO | disclosed |
| US-20140128475-A1 | AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-05-08 | — | — | US | disclosed |
| CN-102283949-B | Spraying agent containing sodium gualenate for treating canker sore | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2014-03-19 | — | — | CN | disclosed |
| CN-102283949-B | Spraying agent containing sodium gualenate for treating canker sore | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2014-03-19 | — | — | CN | disclosed |
| CN-102283949-B | Spraying agent containing sodium gualenate for treating canker sore | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2014-03-19 | — | — | CN | disclosed |
| WO-2014036009-A1 | APPARATUS AND METHODS FOR DRUG DELIVERY USING MICRONEEDLES | CLEARSIDE BIOMEDICAL, INC. (US) | 2014-03-06 | — | — | WO | disclosed |
| CN-102267929-B | Preparation of novel N-amino acid substituted azulene sulfamide medicine and anti-gastric ulcer actions thereof | Sichuan guokang pharmaceutical co ltd | 2014-02-19 | — | — | CN | disclosed |
| CN-102267929-B | Preparation of novel N-amino acid substituted azulene sulfamide medicine and anti-gastric ulcer actions thereof | Sichuan guokang pharmaceutical co ltd | 2014-02-19 | — | — | CN | disclosed |
| US-20140045948-A1 | KIT OF OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-02-13 | — | — | US | disclosed |
| CN-103550102-A | Chinese herbal medicine toothpaste containing radix notoginseng total saponins and lignum vitae sodium azulenesulfonate | GUANGXI AOQILI CO LTD | 2014-02-05 | — | — | CN | disclosed |
| US-20130331458-A1 | KIT OF OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-12-12 | — | — | US | disclosed |
| CN-103405747-A | Preparation, product and application of alanyl glutamine biological adhesive preparation | THIRD PEOPLE S HOSPITAL OF CHONGQING | 2013-11-27 | — | — | CN | disclosed |
| US-20130303624-A1 | OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130303625-A1 | AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130303626-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130303627-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| CN-102379820-B | Sodium gualenate aqueous solution | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2013-09-18 | — | — | CN | disclosed |
| CN-102379820-B | Sodium gualenate aqueous solution | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2013-09-18 | — | — | CN | disclosed |
| US-8454582-B2 | Methods and devices for the treatment of ocular conditions | SURMODICS, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| EP-2039363-B1 | AGENT FOR PREVENTION AND/OR TREATMENT OF GLOMERULOPATHY | MITSUBISHI TANABE PHARMA CORP (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-20120251478-A1 | Method for treatment of a glomerular disease comprising administration of anion exchange resin | YAMAMORI MASAHIKO (JP) | 2012-10-04 | — | — | US | disclosed |
| CN-102018703-B | Azulene sulfonate-containing gynaecological special lotion | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2012-07-25 | — | — | CN | disclosed |
| US-20120171296-A1 | RAPIDLY DISINTEGRATING SOLID PREPARATION | OOKAWA AKIKO (JP) | 2012-07-05 | — | — | US | disclosed |
| CN-102379820-A | Sodium gualenate aqueous solution | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2012-03-21 | — | — | CN | disclosed |
| CN-102379820-A | Sodium gualenate aqueous solution | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2012-03-21 | — | — | CN | disclosed |
| CN-102283949-A | Spraying agent containing sodium gualenate for treating canker sore | — | 2011-12-21 | — | — | CN | disclosed |
| CN-102283949-A | Spraying agent containing sodium gualenate for treating canker sore | — | 2011-12-21 | — | — | CN | disclosed |
| CN-102283949-A | Spraying agent containing sodium gualenate for treating canker sore | — | 2011-12-21 | — | — | CN | disclosed |
| CN-102267929-A | Preparation of novel N-amino acid substituted azulene sulfamide medicine and anti-gastric ulcer actions thereof | — | 2011-12-07 | — | — | CN | disclosed |
| CN-102267929-A | Preparation of novel N-amino acid substituted azulene sulfamide medicine and anti-gastric ulcer actions thereof | — | 2011-12-07 | — | — | CN | disclosed |
| CN-102228417-A | Chinese herbal medicine toothpaste composition containing sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2011-11-02 | — | — | CN | disclosed |
| CN-102228417-A | Chinese herbal medicine toothpaste composition containing sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2011-11-02 | — | — | CN | disclosed |
| CN-102228417-A | Chinese herbal medicine toothpaste composition containing sodium gualenate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2011-11-02 | — | — | CN | disclosed |
| CN-102160886-A | Compound buccal tablet containing sodium azulene sulfonate and application | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2011-08-24 | — | — | CN | disclosed |
| US-20110159073-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS | DEJUAN EUGENE | 2011-06-30 | — | — | US | disclosed |
| CN-101062005-B | Medical toothpaste including sodium azulene sulfonate | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2011-06-08 | — | — | CN | disclosed |
| CN-102018703-A | Azulene sulfonate-containing gynaecological special lotion | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2011-04-20 | — | — | CN | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| CN-1927195-B | Film agent comprising sodium gualenate using for eyes | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2011-02-02 | — | — | CN | disclosed |
| CN-1927195-B | Film agent comprising sodium gualenate using for eyes | TIANJIN DINGSHUO SCIENCE AND TRADE CO LTD | 2011-02-02 | — | — | CN | disclosed |
| US-20100233278-A1 | RAPIDLY DISINTEGRATING SOLID PREPARATION | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-2196221-A1 | RAPIDLY DISINTEGRATING SOLID PREPARATION | Mitsubishi Tanabe Pharma Corporation (JP) | 2010-06-16 | — | — | EP | disclosed |
| US-7674488-B2 | External composition comprising an aqueous extract of red vine leaves and an anti-inflammatory agent | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-03-09 | — | — | US | disclosed |
| US-20090162311-A1 | Agent for Prevention and/or Treatment of Glomerulopathy | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-06-25 | — | — | US | disclosed |
| EP-2039363-A1 | AGENT FOR PREVENTION AND/OR TREATMENT OF GLOMERULOPATHY | Mitsubishi Tanabe Pharma Corporation (JP) | 2009-03-25 | — | — | EP | disclosed |
| CN-100427080-C | Enteroclysis contg. sodium azulene-sulfonate | DINGSHUO SCIENCE & TRADE CO LT (CN) | 2008-10-22 | — | — | CN | disclosed |
| CN-101062005-A | Medical toothpaste including sodium azulene sulfonate | TIANJIN JING SHUO SCIENCE AND (CN) | 2007-10-31 | — | — | CN | disclosed |
| CN-1927195-A | Film agent comprising sodium gualenate using for eyes | TIANJIN JING SHUO SCIENCE AND (CN) | 2007-03-14 | — | — | CN | disclosed |
| CN-1927195-A | Film agent comprising sodium gualenate using for eyes | TIANJIN JING SHUO SCIENCE AND (CN) | 2007-03-14 | — | — | CN | disclosed |
| CN-1861046-A | Enteroclysis contg. sodium azulene-sulfonate | DINGSHUO SCIENCE & TRADE CO LT (CN) | 2006-11-15 | — | — | CN | disclosed |
| EP-1718168-A1 | COMPOSITION FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCIES COMPRISING AN EXTRACT OF RED VINE LEAVES AND AN ANTI-INFLAMMATORY AGENT | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-11-08 | — | — | EP | disclosed |
| CN-1836656-A | Drop pills containing sodium azulenesulfonate ingredient | TIANJIN JING SHUO SCIENCE AND (CN) | 2006-09-27 | — | — | CN | disclosed |
| US-20060110428-A1 | Methods and devices for the treatment of ocular conditions | SURMODICS MD, LLC | 2006-05-25 | — | — | US | disclosed |
| WO-2006043336-A1 | THERAPEUTIC OR PREVENTIVE COMPOSITION FOR GASTRIC MUCOSA DISEASE | KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) | 2006-04-27 | — | — | WO | disclosed |
| WO-2006014484-A2 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS | SURMODICS, INC. (US) | 2006-02-09 | — | — | WO | disclosed |
| US-20050271757-A1 | External composition comprising an aqueous extract of red vine leaves and an ant-inflammatory agent | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-12-08 | — | — | US | disclosed |
| EP-0931539-B1 | Cuticle caring method | KAO CORP (JP) | 2005-10-19 | — | — | EP | disclosed |
| WO-2005079600-A1 | COMPOSITION FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCIES COMPRISING AN EXTRACT OF RED VINE LEAVES AND AN ANTI-INFLAMMATORY AGENT | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-09-01 | — | — | WO | disclosed |
| US-20050089577-A1 | Liquid matrix undergoing phase transfer in vivo and liquid oral preparations | MEDRX CO., LTD. (JP) | 2005-04-28 | — | — | US | disclosed |
| US-20050002865-A1 | Diagnostic/therapeutic agents | AMERSHAM HEALTH AS (NO) | 2005-01-06 | — | — | US | disclosed |
| EP-1488812-A1 | LIQUID MATRIX UNDERGOING PHASE TRANSFER IN VIVO AND LIQUID ORAL PREPARATIONS | Medrx Co. Ltd. (JP) | 2004-12-22 | — | — | EP | disclosed |
| US-20040141922-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2004-07-22 | — | — | US | disclosed |
| US-6680047-B2 | FOR USE IN ULTRASOUND IMAGING, CONTRAST AGENTS | AMERSHAM HEALTH AS (NO) | 2004-01-20 | — | — | US | disclosed |
| CN-1430956-A | Medicine for treating intestinal tract disease | GUOKANG MEDICINE INDUSTRY CO L (CN) | 2003-07-23 | — | — | CN | disclosed |
| US-20020102215-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| US-20020102217-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| US-6355266-B1 | INDOMETHACIN-CONTAINING PATCH; FOR THERAY OF PAIN DUE TO CONTUSION, SPRAIN OR MUSCULAR FATIGUE, AND PAIN ASSOCIATED WITH SHOULDER STIFFNESS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-03-12 | — | — | US | disclosed |
| US-6331289-B1 | ULTRASOUND CONTRAST AGENTS, SUSPENSION IN AQUEOUS CARRIER LIQUID OF A REPORTER COMPRISING GAS-CONTAINING OR GAS-GENERATING MATERIAL, AGENT CAPABLE OF FORMING AT LEAST TWO TYPES OF BINDING PAIRS WITH TARGET; REPORTER BEING CONJUGATED | NYCOMED IMAGING AS (NO) | 2001-12-18 | — | — | US | disclosed |
| US-6264917-B1 | MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT | NYCOMED IMAGING AS (NO) | 2001-07-24 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |
| US-6217855-B1 | ELASTICITY | KAO CORPORATION (JP) | 2001-04-17 | — | — | US | disclosed |
| US-6174523-B1 | Hair cuticle caring method | KAO CORPORATION (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-1029542-A1 | PERCUTANEOUSLY ABSORBABLE PREPARATION | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2000-08-23 | — | — | EP | disclosed |
| EP-0275054-B2 | Ointment base and ointment | TOKO YAKUHIN KOGYO KK (JP) | 2000-01-26 | — | — | EP | disclosed |
| EP-0931539-A2 | Cuticle caring method | KAO CORPORATION (JP) | 1999-07-28 | — | — | EP | disclosed |
| WO-1996025158-A1 | MEDICINAL COMPOSITION CONTAINING AZULENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1996-08-22 | — | — | WO | disclosed |
| JP-H0881351-A | CUTICLE KERATINIZATION PROMOTING AGENT | KANEBO LTD | 1996-03-26 | — | — | JP | disclosed |
| US-5494665-A | METAL CHLORIDE, LYSOZYME CHLORIDE, ISOTONIC AGENT, NONIONIC THICKENING AGENT AND PRESERVATIVE | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1996-02-27 | — | — | US | disclosed |
| EP-0381193-B1 | Film applicable to oral mucosa and drug preparation comprising the same | NITTO DENKO CORP (JP) | 1994-09-07 | — | — | EP | disclosed |
| EP-0595226-A2 | Active substance-containing polymer gel | HOYA CORPORATION (JP) | 1994-05-04 | — | — | EP | disclosed |
| JP-H0543423-A | HAIR TREATING AGENT COMPOSITION | KAO CORP | 1993-02-23 | — | — | JP | disclosed |
| US-5166233-A | Polyvinyl acetate, acrylic acid polymer and cellulose derivative blends | NITTO DENKO CORPORATION (JP) | 1992-11-24 | — | — | US | disclosed |
| US-4983386-A | Adding amino acids to aqueous acrylic polymer solution, controlling ph; radiation resistance | TOKO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1991-01-08 | — | — | US | disclosed |
| EP-0381193-A2 | Film applicable to oral mucosa and drug preparation comprising the same | NITTO DENKO CORPORATION (JP) | 1990-08-08 | — | — | EP | disclosed |
| JP-H02115121-A | ANTAGONIST AGAINST THRONBOXANE A2 AND PROSTAGLANDIN ENDOPEROXIDE | KOTOBUKI SEIYAKU KK | 1990-04-27 | — | — | JP | disclosed |
| JP-H01121216-A | STABLE DRUG PREPARATION CONTAINING SODIUM GUAIAZULENESULFONATE | TAIHO YAKUHIN KOGYO KK | 1989-05-12 | — | — | JP | disclosed |
| EP-0179277-B1 | MEDICAL COMPOSITION FOR EXTERNAL APPLICATION | Kao Corporation (JP) | 1988-11-02 | — | — | EP | disclosed |
| EP-0275054-A1 | Ointment base and ointment | Toko Yakuhin Kogyo Kabushiki Kaisha (JP) | 1988-07-20 | — | — | EP | disclosed |
| JP-S63139118-A | INTRAORAL CLEANING AGENT | NISSHIN KORYO KK | 1988-06-10 | — | — | JP | disclosed |
| JP-S6351341-A | AZULENE-CONTAINING LIQUID FORMULATION | LION CORP | 1988-03-04 | — | — | JP | disclosed |
| JP-S6348211-A | AZULENE-CONTAINING COMPOSITION | LION CORP | 1988-02-29 | — | — | JP | disclosed |
| US-4686211-A | Medical composition for external application | KAO CORPORATION (JP) | 1987-08-11 | — | — | US | disclosed |
| US-4670185-A | ANIONIC, CATIONIC, NONIONIC SURFACTANTS | LION CORPORATION (JP) | 1987-06-02 | — | — | US | disclosed |
| JP-S61293912-A | COMBINED DRUG AND PRODUCTION THEREOF | TEISAN SEIYAKU KK | 1986-12-24 | — | — | JP | disclosed |
| JP-S61151118-A | ARTIFICIAL SALIVA | DAICEL CHEM IND LTD | 1986-07-09 | — | — | JP | disclosed |
| EP-0179277-A1 | Medical composition for external application | Kao Corporation (JP) | 1986-04-30 | — | — | EP | disclosed |
| JP-S60188316-A | ANTI-INFLAMMATORY FOR ORAL CAVITY | BIIBURANDO MEDEIKOO DENTARU:KK | 1985-09-25 | — | — | JP | disclosed |
| JP-S5883667-A | ALUMINUM GUAIAZULENESULFONATE, ITS PREPARATION, AND ANTIULCER COMPRISING IT AS ACTIVE INGREDIENT | KOTOBUKI SEIYAKU KK | 1983-05-19 | — | — | JP | disclosed |
| JP-S5813513-A | PHARMACEUTICAL CONTAINING STABLE SODIUM GUAIAZULENESULFONATE | SHOWA YAKUHIN KAKO KK | 1983-01-26 | — | — | JP | disclosed |
| JP-S5630927-A | STABILIZATION OF GUAIAZULENE AND ITS DERIVATIVE | ZERIA SHINYAKU KOGYO KK | 1981-03-28 | — | — | JP | disclosed |
| JP-S5630927-A | STABILIZATION OF GUAIAZULENE AND ITS DERIVATIVE | ZERIA SHINYAKU KOGYO KK | 1981-03-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (41 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10973767-B2 | Oral drug dosage form comprising drug in the form of nanoparticles | CYP2D6, CYP3A5, CYP3A7 | PTGS1 1763/4885P2RY4 4094/4885P2RY2 4495/4885 |
| US-20160206628-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | AQP4, AQP3, EYA3 | PTGS1 2743/4885P2RY4 991/4885P2RY2 1038/4885 |
| US-20140206741-A1 | N-SUBSTITUTED ISOPROPYLDIMETHYL AZULENE SULFONAMIDE DERIVATIVES, AND PREPARATION METHOD AND USE THEREOF | GIPR, SSTR5, STS | PTGS1 535/4885P2RY4 848/4885P2RY2 618/4885 |
| US-20190192440-A1 | ORAL DRUG DOSAGE FORM COMPRISING DRUG IN THE FORM OF NANOPARTICLES | CYP2D6, CYP3A5, CYP3A7 | PTGS1 1763/4885P2RY4 4094/4885P2RY2 4495/4885 |
| US-20040141922-A1 | Diagnostic/therapeutic agents | BID, FUS, FABP1 | PTGS1 2805/4885P2RY4 4837/4885P2RY2 4820/4885 |
| US-20140128475-A1 | AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE | ALDH1A2, ALDH1A3, PDE6D | PTGS1 138/4885P2RY4 2038/4885P2RY2 2426/4885 |
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | KRT18, HCN4, COL14A1 | PTGS1 3527/4885P2RY4 2793/4885P2RY2 2318/4885 |
| US-10363220-B2 | Compartmented pharmaceutical dosage forms | CYP2D6, CYP3A5, CYP2F1 | PTGS1 1288/4885P2RY4 2916/4885P2RY2 2709/4885 |
| US-20240165089-A1 | METHOD FOR TREATING MYOPIA WITH VINPOCETINE | MYOC, VAMP7, MYOF | PTGS1 2001/4885P2RY4 3756/4885P2RY2 2512/4885 |
| US-20160367584-A1 | PROTECTIVE AGENT FOR KERATOCONJUNCTIVA OR SUPPRESSIVE AGENT FOR KERATOCONJUNCTIVAL DISORDER | UGCG, GBA1, GOLGA2 | PTGS1 491/4885P2RY4 1690/4885P2RY2 1213/4885 |
| US-20230113836-A1 | NEW CONJUGATES OF PEPTIDES AND POLYSACCHARIDE | DSG1, HBG1, IDUA | PTGS1 546/4885P2RY4 1743/4885P2RY2 2722/4885 |
| US-20140315836-A1 | PROTECTIVE AGENT FOR KERATOCONJUNCTIVA OR SUPPRESSIVE AGENT FOR KERATOCONJUNCTIVAL DISORDER | UGCG, GBA1, GOLGA2 | PTGS1 491/4885P2RY4 1690/4885P2RY2 1213/4885 |
| US-20140243419-A1 | MUCOSALLY-APPLIED AGENT FOR PREVENTION, AMELIORATION OR TREATMENT OF RETINAL DISEASE | ALDH1A2, AGER, GLA | PTGS1 32/4885P2RY4 1774/4885P2RY2 1489/4885 |
| US-12324856-B2 | Oral drug dosage form comprising drug in the form of nanoparticles | CYP2D6, CYP3A5, CYP3A7 | PTGS1 1763/4885P2RY4 4094/4885P2RY2 4495/4885 |
| US-11278499-B2 | Oral drug dosage form comprising various release profiles | CYP2D6, CYP3A7, CYP3A5 | PTGS1 1060/4885P2RY4 2471/4885P2RY2 2733/4885 |
| US-20050002865-A1 | Diagnostic/therapeutic agents | FUS, HNRNPF, HNRNPR | PTGS1 2272/4885P2RY4 4117/4885P2RY2 3986/4885 |
| US-12005070-B2 | Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder | UGCG, GBA1, GOLGA2 | PTGS1 491/4885P2RY4 1690/4885P2RY2 1213/4885 |
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | PROKR2, SLC10A2, GLP1R | PTGS1 3480/4885P2RY4 1908/4885P2RY2 1203/4885 |
| US-20150025154-A1 | OPHTHALMIC COMPOSITION | GSTO1, GSTK1, GSTA1 | PTGS1 350/4885P2RY4 1952/4885P2RY2 1893/4885 |
| US-20130331458-A1 | KIT OF OPHTHALMIC COMPOSITION | KIT, F7, GGPS1 | PTGS1 953/4885P2RY4 500/4885P2RY2 555/4885 |
| US-20230331792-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | VIP, MLX, IAPP | PTGS1 940/4885P2RY4 1608/4885P2RY2 2420/4885 |
| US-20160354315-A1 | DOSAGE FORMS AND USE THEREOF | CYP2D6, CYP3A7, CYP3A5 | PTGS1 1122/4885P2RY4 3183/4885P2RY2 3720/4885 |
| US-20140045948-A1 | KIT OF OPHTHALMIC COMPOSITION | KIT, F7, GGPS1 | PTGS1 953/4885P2RY4 500/4885P2RY2 555/4885 |
| US-20190321299-A1 | ORAL DRUG DOSAGE FORM COMPRISING VARIOUS RELEASE PROFILES | CYP2D6, CYP3A7, CYP3A5 | PTGS1 1060/4885P2RY4 2471/4885P2RY2 2733/4885 |
| US-20240342094-A1 | COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS | CYP2D6, CYP3A5, CYP2F1 | PTGS1 1288/4885P2RY4 2916/4885P2RY2 2709/4885 |
| US-20160089345-A1 | KIT OF OPHTHALMIC COMPOSITION | KIT, F7, GGPS1 | PTGS1 953/4885P2RY4 500/4885P2RY2 555/4885 |
| US-20130303627-A1 | OPHTHALMIC COMPOSITION | GSTO1, GSTK1, GSTA1 | PTGS1 350/4885P2RY4 1952/4885P2RY2 1893/4885 |
| US-10258575-B2 | Oral drug dosage forms having desired drug release profiles and uses thereof | CYP2D6, CYP3A5, CYP3A7 | PTGS1 1210/4885P2RY4 2455/4885P2RY2 3003/4885 |
| US-12042562-B2 | 3D printing methods for compartmented pharmaceutical dosage forms | CYP3A43, HTR3D, CYP3A7 | PTGS1 1904/4885P2RY4 863/4885P2RY2 2665/4885 |
| US-20200315971-A1 | 3D PRINTING METHODS FOR COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS | CYP3A43, HTR3D, CYP3A7 | PTGS1 1904/4885P2RY4 863/4885P2RY2 2665/4885 |
| US-20130303625-A1 | AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE | ALDH1A2, ALDH1A3, PDE6D | PTGS1 138/4885P2RY4 2038/4885P2RY2 2426/4885 |
| US-20160136275-A1 | OPHTHALMIC COMPOSITION | PLPBP, CRYAA, CRYAB | PTGS1 424/4885P2RY4 155/4885P2RY2 91/4885 |
| US-20090162311-A1 | Agent for Prevention and/or Treatment of Glomerulopathy | REN, ATP6V1B1, GLS | PTGS1 351/4885P2RY4 1702/4885P2RY2 2176/4885 |
| US-20120251478-A1 | Method for treatment of a glomerular disease comprising administration of anion exchange resin | REN, SLC26A3, GLS | PTGS1 657/4885P2RY4 1216/4885P2RY2 1428/4885 |
| US-20130303624-A1 | OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE | ALDH1A2, PDE6C, PTGER3 | PTGS1 197/4885P2RY4 709/4885P2RY2 774/4885 |
| US-20210205226-A1 | ORAL DRUG DOSAGE FORM COMPRISING DRUG IN THE FORM OF NANOPARTICLES | CYP2D6, CYP3A5, CYP3A7 | PTGS1 1763/4885P2RY4 4094/4885P2RY2 4495/4885 |
| US-20130303626-A1 | OPHTHALMIC COMPOSITION | PLPBP, CRYAA, CRYAB | PTGS1 424/4885P2RY4 155/4885P2RY2 91/4885 |
| US-20160213662-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | AQP4, AQP3, EYA3 | PTGS1 2743/4885P2RY4 991/4885P2RY2 1038/4885 |
| US-20140350119-A1 | OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE | ALDH1A2, PDE6C, PTGER3 | PTGS1 197/4885P2RY4 709/4885P2RY2 774/4885 |
| US-20180311167-A1 | DOSAGE FORMS AND USE THEREOF | CYP2D6, CYP3A7, CYP3A5 | PTGS1 1122/4885P2RY4 3183/4885P2RY2 3720/4885 |
| US-20020102215-A1 | Diagnostic/therapeutic agents | BID, FUS, FABP1 | PTGS1 2981/4885P2RY4 4843/4885P2RY2 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.